volume 35, issue 2, P68-72 2009
DOI: 10.1080/00952990802585406
View full text
|
|
Share

Abstract: Background Diversion of buprenorphine (BPN) has been described in settings where it is legally prescribed and has resulted in increasing concern. To address this concern, co-formulation of buprenorphine/naloxone (BPN/NLX) replaced buprenorphine alone in Malaysia in December 2006. Methods To assess the significance of BPN/NLX introduction, 41 BPN/NLX injectors in Kuala Lumpur, Malaysia were recruited using a modified snowball recruitment technique. Results In January 2007, all subjects had previously inje…

Expand abstract